Encompass Health Corporation
EHC · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $12,766 | $12,337 | $10,179 | $9,235 |
| - Cash | $49 | $99 | $96 | $85 |
| + Debt | $268 | $2,686 | $2,703 | $355 |
| Enterprise Value | $12,985 | $14,923 | $12,786 | $9,504 |
| Revenue | $1,478 | $1,458 | $1,455 | $1,405 |
| % Growth | 1.4% | 0.2% | 3.6% | – |
| Gross Profit | $693 | $627 | $631 | $586 |
| % Margin | 46.9% | 43% | 43.3% | 41.7% |
| EBITDA | $333 | $347 | $350 | $312 |
| % Margin | 22.5% | 23.8% | 24% | 22.2% |
| Net Income | $127 | $142 | $152 | $121 |
| % Margin | 8.6% | 9.7% | 10.4% | 8.6% |
| EPS Diluted | 1.24 | 1.39 | 1.48 | 1.18 |
| % Growth | -10.8% | -6.1% | 25.4% | – |
| Operating Cash Flow | $271 | $270 | $289 | $279 |
| Capital Expenditures | -$187 | -$157 | -$163 | -$199 |
| Free Cash Flow | $84 | $113 | $126 | $80 |